SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-289087
Filing Date
2020-11-09
Accepted
2020-11-09 16:17:31
Documents
16
Period of Report
2020-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d667530d8k.htm   iXBRL 8-K 26767
2 EX-99.1 d667530dex991.htm EX-99.1 200886
6 GRAPHIC g667530im1.jpg GRAPHIC 7537
7 GRAPHIC g667530im2.jpg GRAPHIC 3661
8 GRAPHIC g667530im5.jpg GRAPHIC 3684
  Complete submission text file 0001193125-20-289087.txt   391030

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlry-20201109.xsd EX-101.SCH 2719
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20201109_lab.xml EX-101.LAB 18064
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20201109_pre.xml EX-101.PRE 11262
9 EXTRACTED XBRL INSTANCE DOCUMENT d667530d8k_htm.xml XML 3449
Mailing Address 1100 MAUGHAN ROAD NANAIMO A1 V9X 1J2
Business Address 1100 MAUGHAN ROAD NANAIMO A1 V9X 1J2 2064329325
Tilray, Inc. (Filer) CIK: 0001731348 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 201297916
SIC: 2833 Medicinal Chemicals & Botanical Products